When the U.S. Food and Drug Administration (FDA) announced during a White House press conference last week that it would expand the use of leucovorin as “a promising treatment for symptoms of autism,” it cited an analysis of 23 publications. The Transmitter has obtained the list of the 23 studies—which together examine leucovorin treatment in […]
